TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 173 filers reported holding TRAVERE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $83,797,841 | -30.9% | 3,984,681 | -19.1% | 1.70% | -34.3% |
| Q3 2022 | $121,301,000 | +1.7% | 4,922,941 | 0.0% | 2.59% | -18.6% |
| Q2 2022 | $119,283,000 | -6.0% | 4,922,941 | 0.0% | 3.18% | +14.9% |
| Q1 2022 | $126,864,000 | -27.2% | 4,922,941 | -12.3% | 2.77% | -9.9% |
| Q4 2021 | $174,272,000 | +28.0% | 5,614,428 | 0.0% | 3.07% | +62.9% |
| Q3 2021 | $136,150,000 | +66.2% | 5,614,428 | 0.0% | 1.89% | +43.5% |
| Q2 2021 | $81,915,000 | -41.6% | 5,614,428 | 0.0% | 1.32% | -37.8% |
| Q1 2021 | $140,192,000 | +12.9% | 5,614,428 | +23.2% | 2.11% | +21.7% |
| Q4 2020 | $124,225,000 | – | 4,557,867 | – | 1.74% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,084,300 | $15,820,000 | 3.32% |
| ARMISTICE CAPITAL, LLC | 5,748,000 | $83,863,000 | 1.50% |
| RA Capital Management | 5,614,428 | $81,915,000 | 1.32% |
| Krensavage Asset Management, LLC | 140,000 | $2,043,000 | 0.69% |
| CM Management, LLC | 60,000 | $875,000 | 0.63% |
| Altium Capital Management LP | 170,484 | $2,487,000 | 0.58% |
| HighVista Strategies LLC | 53,498 | $781,000 | 0.55% |
| Sio Capital Management, LLC | 150,000 | $2,189,000 | 0.54% |
| MANGROVE PARTNERS IM, LLC | 295,037 | $4,305,000 | 0.44% |
| Rock Springs Capital Management LP | 1,494,164 | $21,800,000 | 0.43% |